Orion E, Marcos B, Davidovici B, Wolf R. Itch and scratch: scabies and pediculosis. Clin Dermatol. 2006;24(3):168–75.
Article
PubMed
Google Scholar
The Lancet Global Health Blog: “Scabies added to the World Health Organisation list of Neglected Tropical Diseases”. (2014), Available at: http://globalhealth.thelancet.com/2014/07/07/scabies-joins-list-whoneglected-tropical-diseases (Last accessed 19 June 2015).
Connors C. Scabies treatment. Northern Territory Disease Control Bulletin. 1994;2:5–6.
Google Scholar
Clucas DB, Carville KS, Connors C, Currie BJ, Carapetis JR, Andrews RM. Disease burden and health-care clinic attendances for young children in remote Aboriginal communities of northern Australia. Bull World Health Organ. 2008;86(4):275–81.
Article
PubMed
PubMed Central
Google Scholar
McLean FE. The elimination of scabies: a task for our generation. Int J Dermatol. 2013;52(10):1215–23.
PubMed
Google Scholar
Andrews RM, Kearns T, Connors C, et al. A regional initiative to reduce skin infections amongst aboriginal children living in remote communities of the Northern Territory, Australia. PLoS Negl Trop Dis. 2009;3(11):e554.
Article
PubMed
PubMed Central
Google Scholar
Kline K, McCarthy JS, Pearson M, Loukas A, Hotez PJ. Neglected tropical diseases of Oceania: review of their prevalence, distribution, and opportunities for control. PLoS Negl Trop Dis. 2013;7(1):e1755.
Article
PubMed
PubMed Central
Google Scholar
Bouvresse S, Chosidow O. Scabies in healthcare settings. Curr Opin Infect Dis. 2010;23(2):111–8.
Article
PubMed
Google Scholar
Walton SF, Holt DC, Currie BJ, Kemp DJ. Scabies: new future for a neglected disease. Adv Parasitol. 2004;57:309–76.
Article
PubMed
Google Scholar
Jayaraj R, Hales B, Viberg L, Pizzuto S, Holt D, Rolland JM, et al. A diagnostic test for scabies: IgE specificity for a recombinant allergen of Sarcoptes scabiei. Diagn Microbiol Infect Dis. 2011;71(4):403–7.
Strong M, Johnstone P. Interventions for treating scabies (Review). Cochrane Database Syst Rev. 2007;3:CD000320.
PubMed
Google Scholar
Haas N, Lindemann U, Frank K, Sterry W, Lademann J, Katzung W. Rapid and preferential sebum secretion of ivermectin: a new factor that may determine drug responsiveness in patients with scabies. Arch Dermatol. 2002;138(1):1618–9.
Article
PubMed
Google Scholar
FitzGerald D, Grainger RJ, Reid A. Interventions for preventing the spread of infestation in close contacts of people with scabies. Cochrane Database Syst Rev. 2014;2:CD009943.
PubMed
Google Scholar
Scheinfeld N. Controlling scabies in institutional settings. Am J Clin Dermatol. 2004;5(1):31–7.
Article
PubMed
Google Scholar
Paasch U, Haustein UF. Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin. Int J Dermatol. 2000;39(6):463–70.
Article
CAS
PubMed
Google Scholar
Stoevesandt J, Carlé L, Leverkus M, Hamm H. Control of large institutional scabies outbreaks. J Dtsch Dermatol Ges. 2012;10(9):637–47.
PubMed
Google Scholar
Burkhart CG, Burkhart CN, Burkhart KM. An epidemiologic and therapeutic reassessment of scabies. Cutis. 2000;65:233–40.
CAS
PubMed
Google Scholar
Chosidow O. Clinical practices. Scabies. N Engl J Med. 2006;354(16):1718–27.
Article
CAS
PubMed
Google Scholar
Currie BJ, McCarthy JS. Permethrin and ivermectin for scabies. N Engl J Med. 2010;362(8):717–25.
Article
CAS
PubMed
Google Scholar
Hay RJ, Steer AC, Engelman D, Walton S. Scabies in the developing world-its prevalence, complications, and management. Clin Microbiol Infect. 2012;18(4):313–23.
Article
CAS
PubMed
Google Scholar
Kemp DJ, Walton SF, Harumal P, Currie BJ. The Scourge of Scabies. Biologist. 2002;49(1):19–24.
PubMed
Google Scholar
Hicks MI, Elston DM. Scabies. Dermatol Ther. 2009;22(4):279–92.
Article
PubMed
Google Scholar
Hengge UR, Currie BJ, Jager G, Lupi O, Schwartz RA. Scabies: a ubiquitous neglected skin disease. Lancet Infect Dis. 2006;6(12):769–79.
Article
PubMed
Google Scholar
Goldust M, Rezaee E, Hemayat S. Treatment of scabies: comparison of permethrin 5 % versus ivermectin. J Dermatol. 2012;39(6):545–7.
Article
CAS
PubMed
Google Scholar
Usha V, Gopalakrishnan NT. A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. J Am Acad Dermatol. 2000;42(2):236–40.
Article
CAS
PubMed
Google Scholar
Engelman D, Martin DL, Hay RJ, et al. Opportunities to investigate the effects of ivermectin mass drug administration on scabies. Parasit Vectors. 2013;6:106.
Article
CAS
PubMed
PubMed Central
Google Scholar
Haar K, Romani L, Filimone R, et al. Scabies community prevalence and mass drug administration in two Fijian villages. Int J Dermatol. 2014;53(6):739–45.
Article
PubMed
Google Scholar
Kearns T, Andrews R, Speare R, et al. Prevalence of scabies and strongyloidiasis before and after MDA in a remote Aboriginal community in Northern Territory, Australia. Int J Infect Dis. 2014;21(1):252.
Article
Google Scholar
Therapeutic Goods Administration (TGA): “Australian Public Assessment Report for Ivermectin (Stromectol®)”. 2013, Available at: http://www.tga.gov.au/auspar/auspar-ivermectin (Last accessed 19 June 2015).
Australian Prescriber: “New drugs- Ivermectin”. 1997, Available at http://www.australianprescriber.com/magazine/20/3/77/9/new-drugs/149/ivermectin (Last accessed 19 June 2015).
NPS MedicineWise: “Ivermectin (Stromectol) for scabies. NPS Medicine Update”. 2014. Available at: http://www.nps.org.au/publications/consumer/medicine-update/2014/ivermectin-stromectol-for-scabies (Last accessed 24 March 2015).
Heukelbach J, Feldmeier H. Ectoparasites-the underestimated realm. Lancet. 2004;363(9412):889–91.
Article
PubMed
Google Scholar
Mounsey KE, Holt DC, McCarthy J, Currie BJ, Walton SF. Scabies: molecular perspectives and therapeutic implications in the face of emerging drug resistance. Future Microbiol. 2008;3(1):57–66.
Article
CAS
PubMed
Google Scholar
Mounsey KE, Holt DC, McCarthy JS, Currie BJ, Walton SF. Longitudinal evidence of increasing in vitro tolerance of scabies mites to ivermectin in scabies-endemic communities. Arch Dermatol. 2009;145(7):840–1.
Article
PubMed
Google Scholar
Terada Y, Murayama N, Ikemura H, Morita T, Nagata M. Sarcoptes scabiei var. canis refractory to ivermectin treatment in two dogs. Vet Dermatol. 2010;21(6):608–12.
Article
PubMed
Google Scholar
Currie BJ, Harumal P, McKinnon M, Walton SF. First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. Clin Infect Dis. 2004;39(1):e8–12.
Article
CAS
PubMed
Google Scholar
Pasay C, Walton S, Fischer K, Holt D, McCarthy J. PCR-based assay to survey for knockdown resistance to pyrethroid acaricides in human scabies mites (Sarcoptes scabiei var hominis). AmJTrop Med Hyg. 2006;74(4):649–57.
CAS
Google Scholar
Leibowitz MR. Failure of scabies treatment. N Z Med J. 1993;106(960):317–8.
CAS
PubMed
Google Scholar
Pasay C, Arlian L, Morgan M, et al. High-resolution melt analysis for the detection of a mutation associated with permethrin resistance in a population of scabies mites. Med Vet Entomol. 2008;22(1):82–8.
Article
CAS
PubMed
Google Scholar
Fraser J. Permethrin: a Top End viewpoint and experience. Med J Aust. 1994;160(12):806.
CAS
PubMed
Google Scholar
van den Hoek JA, van de Weerd JA, Baayen TD, et al. A persistent problem with scabies in and outside a nursing home in Amsterdam: indications for resistance to lindane and ivermectin. Euro Surveillance. 2008;13(48):19052.
PubMed
Google Scholar
Ly F, Caumes E, Ndaw CA, Ndiaye B, Mahe A. Ivermectin versus benzyl benzoate applied once or twice to treat human scabies in Dakar, Senegal: a randomized controlled trial. Bull World Health Organ. 2009;87(6):424–30.
Article
PubMed
PubMed Central
Google Scholar
Rizvi SDA, Iftikhar N, Batool F. Effectiveness of oral ivermectin for eradicating infesting mites in patients of scabies. J Pak Assoc Dermatol. 2011;21(2):87–92.
Google Scholar
Gilmore SJ. Control strategies for endemic childhood scabies. PLoS ONE. 2011;6(1):e15990.
Article
CAS
PubMed
PubMed Central
Google Scholar
Moberg SA, Lowhagen GB, Hersle KS. An epidemic of scabies with unusual features and treatment resistance in a nursing home. J Am Acad Dermatol. 1984;11(2 Pt 1):242–4.
Article
CAS
PubMed
Google Scholar
Yonkosky D, Ladia L, Gackenheimer L, Schultz MW. Scabies in nursing homes: an eradication program with permethrin 5 % cream. J Am Acad Dermatol. 1990;23(6 Pt 1):1133–6.
Article
CAS
PubMed
Google Scholar
Nnoruka EN, Agu CE. Successful treatment of scabies with oral ivermectin in Nigeria. Trop Dr. 2001;31(1):15–8.
CAS
Google Scholar
Walton SF, Myerscough MR, Currie BJ. Studies in vitro on the relative efficacy of current acaricides for Sarcoptes scabiei var. hominis. Trans R Soc Trop Med Hyg. 2000;94(1):92–6.
Article
CAS
PubMed
Google Scholar
Saqib M, Afridi IU, Ali A, Jahangir M. Scabies; Safety of Permethrin and ivermectin. Professional Med J. 2012;19(1):86.
Google Scholar
Huffam SE, Currie BJ. Ivermectin for Sarcoptes scabiei hyperinfestation. Int J Infect Dis. 1998;2(3):152–4.
Article
CAS
PubMed
Google Scholar
Coskey RJ. Scabies-resistance to treatment with crotamiton. Arch Dermatol. 1979;115(1):109.
Article
CAS
PubMed
Google Scholar
Glaziou P, Cartel J, Alzieu P, Briot C, Moulia-Pelat J, Martin P. Comparison of ivermectin and benzyl benzoate for treatment of scabies. Trop Med Parasitol. 1993;44(4):331–2.
CAS
PubMed
Google Scholar
Brooks P, Grace R. Ivermectin is better than benzyl benzoate for childhood scabies in developing countries. J Paediatr Child Health. 2002;38(4):401–4.
Article
CAS
PubMed
Google Scholar
Fujimoto K, Kawasaki Y, Morimoto K, Kikuchi I, Kawana S. Treatment for crusted scabies: limitations and side effects of treatment with ivermectin. J Nippon Med Sch. 2014;81(3):157–63.
Article
PubMed
Google Scholar
Roos TC, Roos S, Merk HF, Bickers DR. Pharmacotherapy of ectoparasitic infections. Drugs. 2001;61(8):1067–88.
Article
CAS
PubMed
Google Scholar
Walker G, Johnstone P. Interventions for treating scabies (Cochrane Review). Cochrane Database Syst Rev. 2000;3:CD000320.
PubMed
Google Scholar
Coleman CI, Gillespie EL, White CM. Probable topical permethrin‐induced neck dystonia. Pharmacotherapy. 2005;25(3):448–50.
Article
PubMed
Google Scholar
Schultz MW, Gomez M, Hansen RC, Mills J, Menter A, Rodgers H, et al. Comparative study of 5 % permethrin cream and 1 % lindane lotion for the treatment of scabies. Arch Dermatol. 1990;126(2):167–70.
Singalavanija S, Limpongsanurak W, Soponsakunkul S. A comparative study between 10 % sulfur ointment and 0.3 % gamma benzene hexachloride gel in the treatment of scabies in children. J Med Assoc Thail. 2003;86:S531–6.
Google Scholar
Karthikeyan K. Treatment of scabies: newer perspectives. Postgrad Med J. 2005;81(951):7–11.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chouela EN, Abeldano AM, Pellerano G, La Forgia M, Papale RM, Garsd A, et al. Equivalent therapeutic efficacy and safety of ivermectin and lindane in the treatment of human scabies. Arch Dermatol. 1999;135(6):651–5.
del Giudice P. Ivermectin in scabies. Curr Opin Infect Dis. 2002;15(2):123–6.
Article
PubMed
Google Scholar
Barkwell R, Shields S. Deaths associated with ivermectin treatment of scabies. Lancet. 1997;349(9059):1144–5.
Article
CAS
PubMed
Google Scholar